UNSPSC 51342103: Maribavir

This classification denotes a purine antagonist and antiviral agent with the molecular formula C15H19Cl2N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PTB4X93HE1, chemically known as 5,6-dichloro-n-(1-methylethyl)-1-beta-l-ribofuranosyl-1h-benzimidazol-2-amine but generally known as maribavir, which bears US NIH Compound Identifier 122872. European Medicines Agency schedules Maribavir in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03090MIG.

UNSPSC 51342103 Maribavir is a Commodity code for a specific antiviral pharmaceutical product, though recent state and local opportunities tagged under this code show minimal direct activity for maribavir itself. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotic products (Doxycycline Hyclate and Ciprofloxacin Hydrochloride) under an IFB process, and Seminole County, Florida issued an IFB in June 2026 for naloxone and drug deactivation systems for community health initiatives. These opportunities reveal that state and local health agencies use pharmaceutical piggyback and competitive bidding vehicles to source medications and health-related products, typically with quarterly or regular delivery schedules and fixed-fee pricing structures. Issuing bodies include state health departments and county health or community services agencies, which leverage cooperative purchasing consortia (such as MMCAP Infuse) to streamline procurement and access pre-negotiated contracts. Drug-free workplace certification, E-Verify compliance, and insurance requirements (workers' compensation, general liability, professional liability) are standard conditions.

The tagged opportunities span Illinois and Florida, though the recent examples do not specifically target maribavir procurement. The Illinois Department of Public Health piggyback award to Chartwell Rx LLC totaled $2.65 million over 12 months with renewal options for years 2 and 3, with no business enterprise or veterans program utilization required. Seminole County's naloxone and drug deactivation systems procurement called for 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries, an initial two-year term, and potential one-year renewal; the bid response deadline was July 26, 2023. State and local health authorities appear to consolidate pharmaceutical and medical supply procurements through cooperative purchasing and county-level health departments, though the code's application here reflects broader antiviral and public health product sourcing rather than maribavir-specific demand.